Top Markets
#1 BCGame Coin BCGame Coin +5.93%
#2 Tornado Cash Tornado Cash +5.13%
#3 Fake World Assets Fake World Assets +3.87%
#4 StonkBroker StonkBroker +2.14%
#5 Osmosis Osmosis +2.14%
#6 AtomOne AtomOne +2.05%
#7 aPriori aPriori +1.76%
#8 Nockchain Nockchain +1.73%
#9 Ether.fi Ether.fi +1.62%
#10 BORA BORA +1.46%
Coin of the day
BCGame Coin BCGame Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Icosavax, Inc. Icosavax, Inc.

Icosavax, Inc.

ICVX
Rank in Stocks #25854
Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing... Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing immunizations against infectious diseases. Leveraging its proprietary virus-like particle (VLP) platform technology, the company primarily focuses its efforts on severe respiratory illnesses. Its developmental portfolio includes several key vaccine candidates: IVX-121, an RSV-targeted vaccine currently undergoing Phase 1/1b clinical trials; IVX-A12, a bivalent candidate designed to target both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV); IVX-241, a candidate specifically designed for hMPV; and IVX-411, a SARS-CoV-2 vaccine based on a receptor binding domain (RBD) sequence antigen, which is also in Phase 1/2 clinical trials. Established in 2017, Icosavax maintains its corporate headquarters in Seattle, Washington.
Share Price
$15.31
Last synced: 2024-02-29
Market Cap
$45.70M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Icosavax, Inc. (ICVX)

Category

Healthcare
Earnings for Icosavax, Inc. (ICVX)
Earnings in 2026 TTM: 0
According to Icosavax, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Icosavax, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US